We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.74B
AUM Growth
+$18.9M
Cap. Flow
-$61.5M
Cap. Flow %
-3.53%
Top 10 Hldgs %
23.9%
Holding
276
New
11
Increased
44
Reduced
193
Closed
16

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$13M
2
DOCS icon
Doximity
DOCS
+$10.2M
3
LOB icon
Live Oak Bancshares
LOB
+$7.32M
4
RXO icon
RXO
RXO
+$7.31M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.78M

Top Sells

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$24.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$12.4M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$12.3M
4
XPO icon
XPO
XPO
+$7.84M
5
RXT icon
Rackspace Technology
RXT
+$5.42M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Healthcare 26.13%
3 Industrials 15.45%
4 Consumer Discretionary 11.41%
5 Communication Services 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUTR
126
DELISTED
Cutera, Inc.
CUTR
$3.38M 0.19%
76,468
-3,266
-4% -$149K
CBZ icon
127
CBIZ
CBZ
$2.96B
$3.34M 0.19%
71,316
-32,306
-31% -$1.54M
APG icon
128
APi Group
APG
$18.1B
$3.29M 0.19%
262,569
-36,180
-12% -$418K
TCBK icon
129
TriCo Bancshares
TCBK
$1.8B
$3.28M 0.19%
64,366
-2,658
-4% -$139K
DCO icon
130
Ducommun
DCO
$3B
$3.28M 0.19%
65,556
-2,086
-3% -$99.3K
THR
131
DELISTED
Thermon Group Holdings
THR
$3.24M 0.19%
161,528
+18,369
+13% +$341K
QNST icon
132
QuinStreet
QNST
$1.24B
$3.22M 0.18%
224,152
-9,250
-4% -$117K
PRFT
133
DELISTED
Perficient Inc
PRFT
$3.16M 0.18%
45,233
-1,848
-4% -$127K
DCGO icon
134
DocGo
DCGO
$57.6M
$3.06M 0.18%
432,841
-15,692
-3% -$132K
ZUO
135
DELISTED
Zuora, Inc.
ZUO
$3.01M 0.17%
473,981
-7,387
-2% -$52.2K
GRBK icon
136
Green Brick Partners
GRBK
$3.01B
$3M 0.17%
123,902
-5,113
-4% -$118K
HUBG icon
137
HUB Group
HUBG
$2.92B
$2.98M 0.17%
75,012
-3,086
-4% -$121K
MYRG icon
138
MYR Group
MYRG
$5.18B
$2.97M 0.17%
32,300
-1,330
-4% -$121K
TFX icon
139
Teleflex
TFX
$5.94B
$2.91M 0.17%
11,652
-363
-3% -$80.1K
UPLD icon
140
Upland Software
UPLD
$14.6M
$2.9M 0.17%
40,708
+4,206
+12% +$313K
XPEL icon
141
XPEL
XPEL
$1.34B
$2.88M 0.17%
48,028
-1,964
-4% -$125K
LQDT icon
142
Liquidity Services
LQDT
$1.27B
$2.86M 0.16%
203,098
+99,066
+95% +$1.59M
SRDX
143
DELISTED
Surmodics
SRDX
$2.86M 0.16%
83,682
-3,430
-4% -$115K
IRD
144
Opus Genetics
IRD
$307M
$2.85M 0.16%
806,067
+265,719
+49% +$699K
HSKA
145
DELISTED
Heska Corp
HSKA
$2.82M 0.16%
45,416
-471
-1% -$31.8K
ZUMZ icon
146
Zumiez
ZUMZ
$341M
$2.82M 0.16%
129,538
+16,028
+14% +$355K
SLP icon
147
Simulations Plus
SLP
$371M
$2.79M 0.16%
76,199
+9,106
+14% +$383K
MNRO icon
148
Monro
MNRO
$366M
$2.78M 0.16%
61,531
-15,045
-20% -$695K
ICLR icon
149
Icon
ICLR
$12.8B
$2.78M 0.16%
14,301
-105
-0.7% -$20.8K
CW icon
150
Curtiss-Wright
CW
$25.7B
$2.77M 0.16%
16,608
-2,748
-14% -$458K
4 5
6
7 8

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Rice Hall James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Rice Hall James & Associates held 276 positions worth $1.74B, up 1.1% from $1.72B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $61.5M in Q4 2022, closing 16 positions and reducing 193 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in OmniAb worth $8.94M.

  • Rice Hall James & Associates's largest Q4 2022 buy was OmniAb: 2,483,766 shares worth $8.94M.
  • Rice Hall James & Associates added most to Doximity in Q4 2022, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $12.3M.
  • Rice Hall James & Associates fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $24.3M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.74B portfolio in Q4 2022.
  • Rice Hall James & Associates opened 11 new positions and closed 16 in Q4 2022.
  • Rice Hall James & Associates's portfolio value rose 1.1% quarter-over-quarter to $1.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.